Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

September 11, 2021

Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons.

Proceedings of the National Academy of Sciences of the United States of America
Ravi Shankar KeshariFlorea Lupu
September 10, 2021

Liposome-based nanocarriers loaded with anthrax lethal factor and armed with anti-CD19 VHH for effectively inhibiting MAPK pathway in B cells.

International Immunopharmacology
S Reza BanihashemiShahryar Khoshtinat Nikkhoi
September 9, 2021
Open Access

A Stochastic Intracellular Model of Anthrax Infection With Spore Germination Heterogeneity.

Frontiers in Immunology
Bevelynn WilliamsCarmen Molina-París
September 9, 2021
Open Access

Loss of the ClpXP Protease Leads to Decreased Resistance to Cell-Envelope Targeting Antimicrobials in Bacillus anthracis Sterne.

Frontiers in Microbiology
Lang ZouShauna M McGillivray
September 7, 2021

Silkworm model for Bacillus anthracis infection and virulence determination.

Virulence
Atmika PaudelH. Higashi
September 7, 2021

GPS Telemetry Reveals a Zebra With Anthrax as Putative Cause of Death for Three Cheetahs in the Namib Desert.

Frontiers in Veterinary Science
Ruben PortasBettina Wachter
September 4, 2021

No hints for abundance of Bacillus anthracis and Burkholderia pseudomallei in 100 environmental samples from Cameroon.

European Journal of Microbiology & Immunology
Hagen Frickmann, Sven Poppert
September 3, 2021

Pathological findings in African buffaloes (Syncerus caffer) in South Africa.

Journal of the South African Veterinary Association
Daniel B WoodburnEmily P Mitchell
September 2, 2021

Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane-penetrating loop.

Acta Crystallographica. Section D, Structural Biology
F HoelzgenG A Frank
August 27, 2021
Preprint
Open Access

Epitopedia: identifying molecular mimicry of known immune epitopes

BioRxiv : the Preprint Server for Biology
C. A. BalbinJessica Siltberg-Liberles
August 27, 2021
Open Access

A Suggested Diagnostic Approach for Sporadic Anthrax in Cattle to Protect Public Health.

Microorganisms
Jana AvberšekMateja Pate
August 20, 2021
Open Access

Nociceptive Sensory Neurons Mediate Inflammation Induced by Bacillus Anthracis Edema Toxin.

Frontiers in Immunology
Nicole J YangIsaac M Chiu
August 16, 2021

Sex-Specific Elk Resource Selection during the Anthrax Risk Period.

The Journal of Wildlife Management
Anni YangJason K Blackburn

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

© 2021 Meta ULC. All rights reserved
/feed-previews/anthrax-vaccines-asm/53d06e0f-9dc4-4ece-ac00-6bd4b58b4cf5